Marvel Biosciences (TSXV:MRVL) Net Income (Continuing Operations) : C$-1.66 Mil (TTM As of Jan. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Marvel Biosciences's Net Income (Continuing Operations) for the three months ended in Jan. 2025 was C$-0.49 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2025 was C$-1.66 Mil.

Marvel Biosciences Net Income (Continuing Operations) Historical Data

The historical data trend for Marvel Biosciences's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Net Income (Continuing Operations) Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Net Income (Continuing Operations)

-0.96

-3.04

-2.55

-2.29

-1.65

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Net Income (Continuing Operations)	Get a 7-Day Free Trial														-0.23	-0.31	-0.59	-0.28	-0.49

Marvel Biosciences Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.66 Mil.

Marvel Biosciences (TSXV:MRVL) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Marvel Biosciences Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives